Koninklijke Philips NV (PHG)
20.33
+0.29
(+1.45%)
USD |
NYSE |
Mar 27, 16:00
20.32
-0.02
(-0.07%)
Pre-Market: 20:00
Koninklijke Philips Debt to Equity Ratio: 0.5611 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.5611 |
September 30, 2023 | |
June 30, 2023 | 0.6776 |
March 31, 2023 | |
December 31, 2022 | 0.4725 |
September 30, 2022 | |
June 30, 2022 | 0.5433 |
March 31, 2022 | |
December 31, 2021 | 0.3343 |
September 30, 2021 | |
June 30, 2021 | 0.6552 |
March 31, 2021 | |
December 31, 2020 | 0.3988 |
September 30, 2020 | |
June 30, 2020 | 0.6662 |
March 31, 2020 | |
December 31, 2019 | 0.3078 |
September 30, 2019 | |
June 30, 2019 | 0.4887 |
March 31, 2019 | |
December 31, 2018 | 0.2975 |
September 30, 2018 | |
June 30, 2018 | 0.4219 |
March 31, 2018 | |
December 31, 2017 | 0.3247 |
Date | Value |
---|---|
September 30, 2017 | 0.4162 |
June 30, 2017 | 0.2365 |
March 31, 2017 | 0.4209 |
December 31, 2016 | 0.4468 |
September 30, 2016 | 0.4964 |
June 30, 2016 | 0.5056 |
March 31, 2016 | 0.5044 |
December 31, 2015 | 0.4939 |
September 30, 2015 | 0.4846 |
June 30, 2015 | 0.4984 |
March 31, 2015 | 0.5083 |
December 31, 2014 | 0.3777 |
September 30, 2014 | 0.3949 |
June 30, 2014 | 0.3506 |
March 31, 2014 | 0.3374 |
December 31, 2013 | 0.3479 |
September 30, 2013 | 0.3726 |
June 30, 2013 | 0.4098 |
March 31, 2013 | 0.4124 |
December 31, 2012 | 0.4066 |
September 30, 2012 | 0.3899 |
June 30, 2012 | 0.4036 |
March 31, 2012 | 0.409 |
December 31, 2011 | 0.3134 |
September 30, 2011 | 0.2734 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3078
Minimum
Dec 2019
0.6776
Maximum
Jun 2023
0.5105
Average
0.516
Median
Debt to Equity Ratio Benchmarks
Cardinal Health Inc | -1.369 |
TC BioPharm (Holdings) PLC | -- |
uniQure NV | 0.49 |
ProQR Therapeutics NV | 0.1037 |
Adaptimmune Therapeutics PLC | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 32.51B |
Total Liabilities (Quarterly) | 19.17B |
Shareholders Equity (Quarterly) | 13.30B |
Current Ratio | 1.200 |
Net Debt Paydown Yield | -7.06% |